MedPath

MORPHINE SULFATE INJECTION USP

MORPHINE SULFATE INJECTION USP

Approved
DIN Number

02242484

Drug Class

Human

Market Date

Dec 12, 2000

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02242484
AIG Number0104545008
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA01 MORPHINE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular ,  Intravenous ,  Subcutaneous
AHFS Classification28:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

MORPHINE SULFATEActive
Strength: 2 MG / ML
Monograph: MORPHINE SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.